- Regorafenib - the position of this drug in a current daily oncologic practice2019 | Publication without faculty affiliation
- Regorafenib - role of the drug in the current real-life oncological practice2018 | Publication without faculty affiliation
- Regorafenib in the treatment of colorectal cancer2019 | Publication without faculty affiliation
- Regorafenib in the treatment of advanced gastrointestinal stromal tumour +12015 | Publication without faculty affiliation
- Research Report University Hospital for clinical evaluation of BAY 73-4506/15982Publication without faculty affiliation
- Regorafenib monotherapy in pretreated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled clinical trial Phase 32013 | Second Faculty of Medicine
- Gastrointestinal stromal tumour: advances in treatment2020 | Publication without faculty affiliation
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment of gastrointestinal stromal tumour2016 | Publication without faculty affiliation
- Gastrointestinal stromal tumour - the basic algorithm of diagnosis and treatment2014 | Second Faculty of Medicine
- Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis2019 | First Faculty of Medicine
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | First Faculty of Medicine
- Regorafenib jako součást léčebného algoritmu metastazujícího kolorektálního karcinomu2015 | First Faculty of Medicine
- Komentář ke studii: Účinnost a bezpečnost regorafenibu v léčbě pokročilého GIST po selhání imatinibu a sunitinibu - metaanalýza2018 | Publication without faculty affiliation
- Regorafenib v léčbě metastatického kolorektálního karcinomu výsledky u 555 pacientů2020 | First Faculty of Medicine
- urrent treatment options for gastrointestinal stromal tumor2017 | Publication without faculty affiliation
- Systemic treatment of hepatocellular carcinoma2022 | Third Faculty of Medicine
- Patient treated with third-line palliative therapy with tipiracil / trifluridine2020 | Publication without faculty affiliation
- Využití 2. linie systémové léčby u pacienta s hepatocelulárním karcinomem2019 | First Faculty of Medicine
- Lonsurf plus bevacizumab: A new standard in the third-line treatment of metastatic colorectal carcinoma2023 | Publication without faculty affiliation
- Current view on the treatment of colorectal cancer2021 | Publication without faculty affiliation
- Sarcopenia in Metastatic Colorectal Carcinoma2019 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Porovnání výsledků léčby HCC sorafenibem ve studii SHARP a v klinické praxi2019 | First Faculty of Medicine